Stifel maintains its hold rating on Equasens shares, with an unchanged target price of €66. The analyst reports that Equasens has confirmed its long-awaited acquisition of AD Apotheken.
Equasens gained almost 3% in Paris, as Stifel confirmed this morning its hold rating on Equasens shares, with an unchanged target price of 66 euros. The analyst reports that Equasens has confirmed.
Villers-lès-Nancy, 23 November 2023 - 6:00 p.m. PRESS RELEASE Acquisition of the German company ADVand creation of PHARMAGEST Germany EQUASENS, in partnership with ARZ HAAN, a German market.
MIL-OSI: EQUASENS: Acquisition of the German company ADV and creation of PHARMAGEST Germany foreignaffairs.co.nz - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from foreignaffairs.co.nz Daily Mail and Mail on Sunday newspapers.